Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

A list of investigators of the International Salofalk OD Study Group is given in the appendix. Investigators from Latvia are: Jelena Derova, Aleksejs Derovs, Juris Pokrotnieks, Aldis Pukitis, Mairita Ergle.Objectives: To determine the therapeutic equivalence and safety of once daily (OD) versus three times daily (TID) dosing of a total daily dose of 3 g Salofalk (mesalazine) granules in patients with active ulcerative colitis. Design: A randomised, double-blind, double-dummy, parallel group, multicentre, international, phase III noninferiority study. Setting: 54 centres in 13 countries. Patients: 380 patients with confirmed diagnosis of established or first attack of ulcerative colitis (clinical activity index (CAI)>4 and endoscopic index ≥ 4 at baseline) were randomised and treated. Interventions: 8-week treatment with either 3 g OD or 1 g TID mesalazine granules. Main outcome measures: Clinical remission (CAI ≤ 4) at study end. Results: 380 patients were evaluable for efficacy and safety by intention-to-treat (ITT); 345 for per protocol (PP) analysis. In the ITT population, 79.1% in the OD group (n = 191) and 75.7% in the TID group (n = 189) achieved clinical remission (p<0.0001 for non-inferiority). Significantly more patients with proctosigmoiditis achieved clinical remission in the OD group (86%; n = 97) versus the TID group (73%; n = 100; p = 0.0298). About 70% of patients in both treatment groups achieved endoscopic remission, and 35% in the OD group and 41% in the TID group achieved histological remission. About 80% of all patients preferred OD dosing. Similar numbers of adverse events occurred in 55 patients (28.8%) in the OD group and in 61 patients (32.3%) in the TID group, indicating that the two dosing regimens were equally safe and well tolerated. Conclusions: OD 3 g mesalazine granules are as effective and safe as a TID 1 g schedule. With respect to the best possible adherence of patients to the treatment, OD dosing of mesalazine should be the preferred application mode in active ulcerative colitis. ClinicalTrials.gov Identifier: NCT00449722.publishersversionPeer reviewe

Use of unconventional energy sources in modern buildings

Dotychczas mało uwagi poświęcano tematowi zastosowania niekonwencjonalnych źródeł energii w budynkach wyposażonych w inteligentne systemy automatyki. Coraz większa popularności inteligentnych systemów budynkowych sprzyja wykorzystywaniu ich w nowych układach zasilania. Takim nowym zastosowaniem jest współpraca instalacji inteligentnej ze źródłem energii słonecznej. W artykule przedstawiono stanowisko laboratoryjne integrujące instalacją magistralną KNX/EIB z panelem fotowoltaicznym.So far, little attention has been paid to the topic of application of non-conventional energy sources in the buildings equipped with intelligent automation systems. The growing popularity of intelligent building systems promotes their use in new power systems. One such new application is the installation of intelligent co-operation with the source of solar energy

The Effects of Field Intensity and Pneumatic Pressure on the Dielectric Constant of Rye Kernels

Rosana G. Moreira, Editor-in-Chief; Texas A&M UniversityThis is a Technical article from International Commission of Agricultural Engineering (CIGR, Commission Internationale du Genie Rural) E-Journal Volume 3 (2001): M. Horynski. The Effects of Field Intensity and Pneumatic Pressure on the Dielectric Constant of Rye Kernels. Vol. III, May 2001